Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS). 

Biotechnology

Passage Bio

William Chou

Pamela H.

Samiah A. A.

Karl Whitney

Rich Mastropietro

Derek Kichula

Patricia Elsasser

Chelsea Difebbo Ortiz

Anne Marie Pierce

Steve Krausert

Glen Kerker II

Sue Browne

Stuart Henderson

Tiffini Voss

Eden Fucci

Edgar B. Cale

Samiah Al-Zaidy

James M. Wilson

Leadership Team

Scientific Research and Development

Clinical Operations and Quality Assurance

Finance and Administrative Support

��

Teams at Passage Bio

Leadership Team

Scientific Research and Development

Clinical Operations and Quality Assurance

Finance and Administrative Support

��������

Teams at Passage Bio

Leadership Team

Scientific Research and Development

Clinical Operations and Quality Assurance

Finance and Administrative Support

��